0000749660-20-000046.txt : 20201207
0000749660-20-000046.hdr.sgml : 20201207
20201207164158
ACCESSION NUMBER: 0000749660-20-000046
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201203
FILED AS OF DATE: 20201207
DATE AS OF CHANGE: 20201207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stevens Stacey M
CENTRAL INDEX KEY: 0001362512
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-09341
FILM NUMBER: 201373179
MAIL ADDRESS:
STREET 1: C/O ICAD, INC.
STREET 2: 98 SPIT BROOK ROAD, SUITE 100
CITY: NASHUA
STATE: NH
ZIP: 03062
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ICAD INC
CENTRAL INDEX KEY: 0000749660
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 020377419
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 98 SPIT BROOK ROAD, SUITE 100
CITY: NASHUA
STATE: NH
ZIP: 03062
BUSINESS PHONE: 603-882-5200
MAIL ADDRESS:
STREET 1: 98 SPIT BROOK ROAD, SUITE 100
CITY: NASHUA
STATE: NH
ZIP: 03062
FORMER COMPANY:
FORMER CONFORMED NAME: HOWTEK INC
DATE OF NAME CHANGE: 19920703
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2020-12-03
0
0000749660
ICAD INC
icad
0001362512
Stevens Stacey M
C/O ICAD, INC.
98 SPIT BROOK ROAD, SUITE 100
NASHUA
NH
03062
0
1
0
0
President
Common Stock
2020-12-03
4
M
0
1100
6.68
A
172888
D
Common Stock
2020-12-03
4
S
0
1100
11.0736
D
171788
D
Common Stock
2020-12-04
4
M
0
18665
6.68
A
190453
D
Common Stock
2020-12-04
4
S
0
18665
11.2768
D
171788
D
Employee Stock Option (right to buy)
6.68
2020-12-03
4
M
0
1100
0
D
2015-06-19
2024-06-19
Common Stock
1100
0
D
Employee Stock Option (right to buy)
6.68
2020-12-04
4
M
0
5567
0
D
2015-06-19
2024-06-19
Common Stock
5567
0
D
Employee Stock Option (right to buy)
6.68
2020-12-04
4
M
0
6667
0
D
2016-06-19
2024-06-19
Common Stock
6667
0
D
Employee Stock Option (right to buy)
6.68
2020-12-04
4
M
0
6431
0
D
2017-06-19
2024-06-19
Common Stock
6431
0
D
These share were sold pursuant to the Reporting Person's written trading plan pursuant to Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.00 to $11.63 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by it at each separate price on December 3, 2020 and December 4, 2020.
/s/ Annette Heroux, Attorney-in-Fact
2020-12-07